Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) P/E ratio
As of 5 November 2026, Guardian Pharmacy Services, Inc. (GRDN) trades at a P/E ratio of 37.8×. Over the past ten years it has ranged from 0.0× (September 2025) to 51.1× (June 2026); the current reading is higher than 32% of that period. That is above the Medical Care Facilities industry median of 17.4× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 38.1× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 38.8× | (2.60%) |
| Jun 2026 | 39.9× | (10.00%) |
| Mar 2026 | 44.3× | 16.32% |
| Dec 2025 | 38.1× | (5.61%) |
| 8 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SGRY Surgery Partners, Inc. compare | n/m |
| ACHC Acadia Healthcare Company, Inc. compare | n/m |
| BKD Brookdale Senior Living Inc. compare | n/m |
| AVAH Aveanna Healthcare Holdings Inc. compare | 10.5× |
| MD Pediatrix Medical Group, Inc. compare | 17.1× |
| ADUS Addus HomeCare Corporation compare | 21.1× |
| NHC National HealthCare Corporation compare | 28.2× |
| GRDN Guardian Pharmacy Services, Inc. | 37.8× |
| ASTH Astrana Health, Inc. compare | 46.8× |
| Medical Care Facilities industry median | 17.4× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on GRDN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement